Literature DB >> 23637650

Comparison of cytokine responses with anti-d and intravenous immunoglobulin in idiopathic thrombocytopenia.

Sujoy Khan1.   

Abstract

Entities:  

Year:  2013        PMID： 23637650      PMCID： PMC3635956          DOI： 10.1159/000345740

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN： 1660-3796            Impact factor:   3.747


× No keyword cloud information.
  5 in total

1.  Clinical significance of serum cytokine levels and thrombopoietic markers in childhood idiopathic thrombocytopenic purpura.

Authors:  Giovanni Carlo Del Vecchio; Paola Giordano; Riccardina Tesse; Laura Piacente; Maria Altomare; Domenico De Mattia
Journal:  Blood Transfus       Date:  2011-11-15       Impact factor: 3.443

2.  Rozrolimupab, symphobodies against rhesus D, for the potential prevention of hemolytic disease of the newborn and the treatment of idiopathic thrombocytopenic purpura.

Authors:  Roberto Stasi
Journal:  Curr Opin Mol Ther       Date:  2010-12

3.  Release of cytokines and soluble cytokine receptors after intravenous anti-D treatment in children with chronic thrombocytopenic purpura.

Authors:  I Malinowska; A Obitko-Płudowska; E S Buescher; M Wasik; R Rokicka-Milewska
Journal:  Hematol J       Date:  2001

4.  Influence of Intravenous Immunoglobulin Treatment on Thrombopoiesis.

Authors:  Oliver Meyer; Oliver Winter; Abdulgabar Salama
Journal:  Transfus Med Hemother       Date:  2012-05-15       Impact factor: 3.747

5.  Intravenous (IV) anti-D and IV immunoglobulin achieve acute platelet increases by different mechanisms: modulation of cytokine and platelet responses to IV anti-D by FcgammaRIIa and FcgammaRIIIa polymorphisms.

Authors:  Nichola Cooper; Nancy M Heddle; Masja Haas; Marion E Reid; Martin L Lesser; Howard B Fleit; B M R Woloski; James B Bussel
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.